Clinical aspects: specificity and mode of action of immunosuppressives.
D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001379:Azathioprine / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007978:Levamisole / Q000627:therapeutic use; D010396:Penicillamine / Q000627:therapeutic use; D010648:Phenylacetates / Q000627:therapeutic use; D051381:Rats; D013997:Time Factors
D000962:Antimalarials; D007166:Immunosuppressive Agents; D010648:Phenylacetates; D007978:Levamisole; D006046:Gold; D010396:Penicillamine; D001379:Azathioprine